Catalyst Funds Management Pty LTD Taysha Gene Therapies, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $382 Billion
- Q1 2025
A detailed history of Catalyst Funds Management Pty LTD transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 11,900 shares of TSHA stock, worth $32,130. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,900Holding current value
$32,130% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TSHA
# of Institutions
127Shares Held
151MCall Options Held
70KPut Options Held
4.7K-
Avoro Capital Advisors LLC New York, NY20MShares$54 Million0.45% of portfolio
-
Rtw Investments, LP New York, NY18.8MShares$50.7 Million0.43% of portfolio
-
Morgan Stanley New York, NY16.8MShares$45.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$31.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$29.4 Million0.31% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $131M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...